Endoscopic Sleeve Gastroplasty Results in Significant Weight Loss in Obese Patients

November 22, 2022

The findings of a recent study, published in Lancet, suggest that endoscopic sleeve gastroplasty (ESG) is a safe and effective intervention for managing weight loss in obese patients.

 

This study was a randomized trial, conducted at nine US centers, that included 209 participants between 21 and 65 years of age. Each participant was randomly assigned to either an ESG group or lifestyle modifications (control group) between Dec 20, 2017, and June 14, 2019. Lifestyle modifications included a diet based on low calories and physical activities.

 

The results showed that at 52 weeks, participants in the ESG group had an improved result pertaining to one or more comorbidities in comparison with the control group.

 

Thus, ESG shows important improvements in metabolic comorbidities and can be considered as a significant weight loss intervention for obese patients.

Reference:

Abu Dayyeh BK, Bazerbachi F, Vargas EJ, Sharaiha RZ, Thompson CC, Thaemert BC, Teixeira AF, Chapman CG, Kumbhari V, Ujiki MB, Ahrens J, Day C; MERIT Study Group, Galvao Neto M, Zundel N, Wilson EB. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022 Aug 6;400(10350):441-451.

Source link: 

https://pubmed.ncbi.nlm.nih.gov/35908555/

Share on Social Platforms :

Related Articles

Ask an

Expert

We are here to provide you the best service, to help you with all our expertise….
Please leave a message and we will try to reach you very soon

Obesity linked

Obesity linked with worse heart health despite regular exercise

A new study published in the European Journal of Preventive Cardiology suggests that physical activity does not undo the negative effects of excess body weight on heart health. The observational study assessed the association between different body mass index (BMI) categories and physical activity levels, and the prevalence of major cardiovascular disease (CVD) risk factors.
Data from 527,662 working adults of average age 42 years was used for the study. The participants were categorized as normal weight (BMI, 20.0–24.9 kg•m−2), overweight (BMI, 25.0–29.9 kg•m−2), or obese (BMI ≥ 30.0 kg•m−2). They were also grouped by their activity level – regularly active, insufficiently active, and inactive. Cardiovascular health was evaluated according to the major risk factors for heart attack and stroke, specifically diabetes, high cholesterol, and high blood pressure. Logistic regression was used to determine the association between each BMI and physical activity group and the prevalence of CVD risk factors. About 42% of participants had normal weight, 41% were overweight, and 18% were obese. Approximately 63.5% were inactive, 12.3% were insufficiently active, and 24.2% were regularly active. Nearly 30% had high cholesterol, 15% had high blood pressure, and 3% had diabetes. In all the BMI groups, any activity was associated with a reduced risk of diabetes, high blood pressure or high cholesterol. However, overweight and obese participants were at increased risk of CVD than the participants with normal weight, regardless of activity levels. Compared to inactive normal weight individuals, active obese people had about two times risk of having high cholesterol, about four times more likely to have diabetes, and nearly five times increased risk of high blood pressure. Hence, the findings of this study showed that weight loss is required to reduce the CVD risk in obese or overweight individuals. But increasing physical activity can have overall health benefits for all BMI categories. Reference: Pedro L Valenzuela et al. Joint association of physical activity and body mass index with cardiovascular risk: a nationwide population-based cross-sectional study, European Journal of Preventive Cardiology (2021).